InsidersTradesSigma
Total declarations
Companies
▲ Purchases (30 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
30
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Goeddel David V, Director. Officer active across 2 companies, notably Tenaya Therapeutics, Inc.. In total, 32 reports have been recorded. Breakdown: 30 buys · 0 sell. Total volume traded: €79.8m. Activity tracked since 3 August 2021. The latest transaction was disclosed on 5 March 2025 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Goeddel David V
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations32 total
35,714,284 shares@ US$0.7038.6% of flowCommon StockSEC:0000950170-25-035788:0
Canonical exit: 3 Jun 2025 (T+90)
134,180 sharesCommon StockSEC:0000950142-24-000999:0
2,222,222 shares@ US$4.5015.2% of flowCommon StockSEC:0000950170-24-015219:0
Canonical exit: 12 May 2024 (T+90)
2,720 shares@ US$0.70540.0% of flowCommon StockSEC:0000950170-23-064842:0
Canonical exit: 13 Feb 2024 (T+90)
6,779 shares@ US$2.59560.0% of flowCommon StockSEC:0000899243-23-008389:0
Canonical exit: 8 Jun 2023 (T+90)
1,500,000 shares@ US$2.606.0% of flowCommon StockSEC:0000899243-23-004580:0
Canonical exit: 9 May 2023 (T+90)
7,542 shares@ US$4.99960.2% of flowCommon StockSEC:0000899243-23-003129:0
Canonical exit: 30 Apr 2023 (T+90)
9,900 shares@ US$4.99940.2% of flowCommon StockSEC:0000899243-23-002621:0
Canonical exit: 23 Apr 2023 (T+90)
37,639 shares@ US$4.99760.9% of flowCommon StockSEC:0000899243-23-002371:0
Canonical exit: 19 Apr 2023 (T+90)
69,739 shares@ US$2.49790.3% of flowCommon StockSEC:0000899243-23-002377:0
Canonical exit: 19 Apr 2023 (T+90)
49,463 shares@ US$2.49470.2% of flowCommon StockSEC:0000899243-23-002158:0
Canonical exit: 17 Apr 2023 (T+90)
5,378 shares@ US$4.94660.1% of flowCommon StockSEC:0000899243-23-001851:0
Canonical exit: 12 Apr 2023 (T+90)
100,070 shares@ US$4.84182.4% of flowCommon StockSEC:0000899243-23-001690:0
Canonical exit: 10 Apr 2023 (T+90)
300 shares@ US$4.97670.0% of flowCommon StockSEC:0000899243-22-038460:0
Canonical exit: 12 Mar 2023 (T+90)
35,997 shares@ US$4.99880.9% of flowCommon StockSEC:0000899243-22-036908:0
Canonical exit: 19 Feb 2023 (T+90)
9,615,384 shares@ US$2.6039.7% of flowCommon StockSEC:0000899243-22-036907:0
Canonical exit: 19 Feb 2023 (T+90)
104,090 shares@ US$4.98712.8% of flowCommon StockSEC:0000899243-22-035273:0
Canonical exit: 1 Feb 2023 (T+90)
76,877 shares@ US$4.86022.0% of flowCommon StockSEC:0000899243-22-034564:0
Canonical exit: 25 Jan 2023 (T+90)
51,046 shares@ US$4.74841.3% of flowCommon StockSEC:0000899243-22-034355:0
Canonical exit: 23 Jan 2023 (T+90)
50,000 shares@ US$3.18280.9% of flowCommon StockSEC:0000899243-22-033838:0
Canonical exit: 15 Jan 2023 (T+90)
951,684 shares@ US$13.5063.9% of flowCommon StockSEC:0000899243-22-022210:0
Canonical exit: 7 Sept 2022 (T+90)
33,071 shares@ US$13.03332.1% of flowCommon StockSEC:0000899243-22-021211:0
Canonical exit: 31 Aug 2022 (T+90)
59,766 shares@ US$13.46584.0% of flowCommon StockSEC:0000899243-22-020683:0
Canonical exit: 29 Aug 2022 (T+90)
19,534 shares@ US$13.49351.3% of flowCommon StockSEC:0000899243-22-020199:0
Canonical exit: 24 Aug 2022 (T+90)
17,240 shares@ US$13.3681.1% of flowCommon StockSEC:0000899243-22-019685:0
Canonical exit: 22 Aug 2022 (T+90)
25 of 32 declarations
About Goeddel David V
Administrateur, GOEDDEL DAVID V has filed 32 disclosures in total. Across the 32 sampled filings between 2021-08-04 and 2025-03-07, all transactions are acquisitions, for a total of 79836587 EUR, mainly in Tenaya Therapeutics, Inc. and NGM Biopharmaceuticals INC.
